TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer

Published:2017-07-17 Issue:18 Volume:77 Page:5077-5094
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Cooper Jonathan M.,Ou Yi-Hung,McMillan Elizabeth A.,Vaden Rachel M.,Zaman Aubhishek,Bodemann Brian O.,Makkar Gurbani,Posner Bruce A.,White Michael A.

Funder

NIH

Welch Foundation

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon signaling and ferroptosis in tumor immunology and therapy;npj Precision Oncology;2024-08-10

2. TBK1 is paradoxical in tumor development: a focus on the pathway mediating IFN-I expression;Frontiers in Immunology;2024-08-05

3. Lysosomal TBK1 responds to amino acid availability to relieve Rab7-dependent mTORC1 inhibition;The EMBO Journal;2024-08-05

4. Stratifin-mediated activation of AKT signaling and therapeutic targetability in hepatocellular carcinoma progression;Cell Insight;2024-08

5. MARCH1 negatively regulates TBK1-mTOR signaling pathway by ubiquitinating TBK1;BMC Cancer;2024-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP